XenTech is a specialized Biotech CRO that focuses on translational oncology research, offering comprehensive preclinical services—including patient-derived tumor xenograft (PDX) and canine xenograft (CDX) models—to assess the anti-cancer efficacy of drug candidates. Beyond service delivery, the company runs internal R&D programs that integrate drug response data with tumor molecular profiles, enabling the discovery of novel biomarkers and therapeutic targets. By combining state-of-the-art in vivo and in vitro assays with a data-driven biomarker pipeline, XenTech delivers actionable insights that accelerate the development of next-generation cancer therapies. Its collaborative approach and commitment to precision oncology set it apart in the competitive CRO landscape.
Open Positions
Technicien(ne) en Expérimentation in Vivo - CDI
Scientific background, 5+ years experience, animal experimentation certification, and good communication skills